Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuaki Taguchi

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Frontiers in Medical Technology|January 9, 2023
Research of storable and ready-to-use artificial red blood cells (hemoglobin vesicles) for emergency medicine and other clinical applicationsHiromi Sakai, Tomoko Kure, Kazuaki Taguchi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 27, 2022
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation modelsSho Tashiro, Kazuaki Taguchi, Yuki Enoki, et al.
Journal of Functional Biomaterials|March 25, 2017
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen CarriersKazuaki Taguchi, Keishi Yamasaki, Toru Maruyama, et al.
Journal of Pharmaceutical Sciences|April 18, 2017
The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable DisordersKazuaki Taguchi, Keishi Yamasaki, Hiromi Sakai, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2019
Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation techniqueKotaro Kimura, Keishi Yamasaki, Koji Nishi, et al.
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
When Red Blood Cells Meet Carbon Monoxide: Yin and Yang in Medicines and PharmaceuticalsTaisei Nagasaki, Victor Tuan Giam Chuang, Masaki Otagiri, et al.
FASEB Bioadvances|October 9, 2023
A combination of 5/6-nephrectomy and unilateral ureteral obstruction model accelerates progression of remote organ fibrosis in chronic kidney diseaseKyoka Homma, Yuki Enoki, Sato Uchida, et al.
Journal of Pharmaceutical Sciences|May 11, 2012
Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applicationsKazuaki Taguchi, Victor Tuan Giam Chuang, Toru Maruyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2012
Carbon monoxide-bound red blood cells protect red blood cell transfusion-induced hepatic cytochrome P450 impairment in hemorrhagic-shock ratsShigeru Ogaki, Kazuaki Taguchi, Hiroshi Watanabe, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 7, 2019
Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray dryingKeishi Yamasaki, Kazuaki Taguchi, Koji Nishi, et al.
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Frontiers in Medical Technology|January 9, 2023
Research of storable and ready-to-use artificial red blood cells (hemoglobin vesicles) for emergency medicine and other clinical applicationsHiromi Sakai, Tomoko Kure, Kazuaki Taguchi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 27, 2022
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation modelsSho Tashiro, Kazuaki Taguchi, Yuki Enoki, et al.
Journal of Functional Biomaterials|March 25, 2017
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen CarriersKazuaki Taguchi, Keishi Yamasaki, Toru Maruyama, et al.
Journal of Pharmaceutical Sciences|April 18, 2017
The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable DisordersKazuaki Taguchi, Keishi Yamasaki, Hiromi Sakai, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2019
Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation techniqueKotaro Kimura, Keishi Yamasaki, Koji Nishi, et al.
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
When Red Blood Cells Meet Carbon Monoxide: Yin and Yang in Medicines and PharmaceuticalsTaisei Nagasaki, Victor Tuan Giam Chuang, Masaki Otagiri, et al.
FASEB Bioadvances|October 9, 2023
A combination of 5/6-nephrectomy and unilateral ureteral obstruction model accelerates progression of remote organ fibrosis in chronic kidney diseaseKyoka Homma, Yuki Enoki, Sato Uchida, et al.
Journal of Pharmaceutical Sciences|May 11, 2012
Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applicationsKazuaki Taguchi, Victor Tuan Giam Chuang, Toru Maruyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2012
Carbon monoxide-bound red blood cells protect red blood cell transfusion-induced hepatic cytochrome P450 impairment in hemorrhagic-shock ratsShigeru Ogaki, Kazuaki Taguchi, Hiroshi Watanabe, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 7, 2019
Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray dryingKeishi Yamasaki, Kazuaki Taguchi, Koji Nishi, et al.
Pageof 20